ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,358.88
-0.06%
Brent Oil
82.29
-0.12%
Bitcoin
61,134.02
-0.51%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oncolytics Biotech Inc (ONCY)

  7. Oncolytics Biotech Inc (ONCY) News

Oncolytics Biotech (ONCY)

Oncolytics Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONCY
DateTimeSourceHeadlineSymbolCompany
09/05/202421:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
09/05/202421:36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
09/05/202417:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
08/05/202418:43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
07/03/202421:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
05/03/202418:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
04/03/202417:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
28/02/202418:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
14/02/202413:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
09/01/202413:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
04/01/202418:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
07/12/202315:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
09/11/202318:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
09/11/202318:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
03/11/202318:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
03/11/202315:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
03/11/202315:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
23/10/202317:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
23/10/202317:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
20/10/202320:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
16/10/202318:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
26/09/202317:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
26/09/202313:00PR Newswire (US)THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSNASDAQ:ONCYOncolytics Biotech Inc
19/09/202322:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
06/09/202317:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
14/08/202314:49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
14/08/202313:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
04/08/202320:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
04/08/202319:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ONCYOncolytics Biotech Inc
22/06/202314:23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ONCYOncolytics Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:ONCY

Your Recent History

LSE
SYME
Supply@me Capital
LSE
TRT
Transense Technologies
LSE
QBT
Quantum Blockchain Techn...
LSE
TRIN
Trinity Exploration & Pr...
LSE
XTR
Xtract Resources
LSE
PET
Petrel Resources
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved